Therapeutic use of anti-tf-antigen antibody

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) A61K 51/10 (2006.01) A61P 35/04 (2006.01)

Patent

CA 2582252

The invention is related to administration of monoclonal antibody JAA-Fl 1 to an individual for inhibition of metastasis and/or inhibition of growth of cells which express TF~Ag, or for detection of tumors or metastatic foci which express TF-Ag. For inhibition of metastasis or inhibition of growth of cells expressing TF-Ag, the method comprises administering to the individual a therapeutic amount of mAb JAA-F11, wherein the JAA-F11 mAb inhibits the metastasis and/or growth of the TF-Ag expressing cancer cells. For detection of tumors or metastatic foci, mAb JAA-F11 is conjugated to a detectable label and administered to the individual. Detection of the label identifies metatstatic foci or tumors which comprise cancer cells expressing TF-Ag.

La présente invention a trait à l'administration d'un anticorps monoclonal JAA-F11 à un sujet pour l'inhibition de métastase et/ou l'inhibition de croissance de cellules d'expression de TF-Ag, ou pour la détection de tumeurs ou de foyers métastatiques d'expression de TF-Ag. Pour l'inhibition de métastase ou l'inhibition de croissance de cellules d'expression de TF-Ag, le procédé comprend l'administration au sujet d'une quantité thérapeutique d'anticorps monoclonal JAA-F11, selon lequel l'anticorps JAA-F11 assure l'inhibition de métastase et/ou de croissance de cellules cancéreuses d'expression de TF-Ag. Pour la détection de tumeurs ou de foyers métastatiques, l'anticorps monoclonal JAA-F11 est conjugué à un traceur détectable et administré au sujet. La détection du traceur identifie les foyers métastatiques ou tumeurs comportant des cellules cancéreuses d'expression de TF-Ag.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic use of anti-tf-antigen antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic use of anti-tf-antigen antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of anti-tf-antigen antibody will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1832892

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.